Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,142 across all filing types
Latest filing 2008-12-23 Merger & Acquisition
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
Merger & Acquisition 2008
Merger & Acquisition Classification · 100% confidence The document is a Schedule TO-T/A filing, which is an amendment to a Tender Offer Statement under the Securities Exchange Act of 1934. It involves Johnson & Johnson and Maple Merger Sub, Inc. making an offer to purchase shares of Mentor Corporation. The text includes detailed correspondence with the SEC, references to tender offer conditions, offer to purchase, and signatures certifying the information. This type of filing is related to merger and acquisition activity, specifically tender offers. The presence of Schedule TO and the context of the document clearly indicate it is related to M&A activity filings rather than a general regulatory filing or other categories. Therefore, the correct classification is Merger & Acquisition (MA).
2008-12-23 English
M&A Activity 2008
M&A Activity Classification · 95% confidence The document is a detailed correspondence letter responding to SEC comments on a Schedule TO-T filing related to a tender offer by Johnson & Johnson and Maple Merger Sub, Inc. for Mentor Corporation. It includes references to tender offer terms, conditions, regulatory compliance, and amendments to the Schedule TO filings. The Schedule TO is a tender offer statement filed under the Securities Exchange Act of 1934, which is a regulatory filing related to M&A activity. The document is not the tender offer statement itself but a correspondence and amendment related to it. Given the detailed nature and the focus on the tender offer process and regulatory comments, this document fits best under the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids. The document length and content confirm it is not a brief announcement or a simple regulatory filing but a substantive M&A-related filing.
2008-12-19 English
Merger & Acquisition 2008
Merger & Acquisition Classification · 95% confidence The document is a letter dated December 17, 2008, from legal counsel representing Johnson & Johnson and Binder Merger Sub, Inc. It references multiple filings with the SEC, specifically Schedule TO-C, Schedule TO-T, and amendments thereto, which are related to tender offers. The letter is a supplemental response to SEC comments regarding the Schedule TO filings, discussing the applicability of Rule 13e-3 and details about the transaction and control considerations. The presence of Schedule TO filings and the involvement of the Office of Mergers & Acquisitions at the SEC indicate this document pertains to a merger or acquisition transaction. The letter is not a full merger proxy statement or tender offer document itself but a correspondence supplementing such filings. Given the context and references, the document fits best under the category of Merger & Acquisition (MA) filings, which include merger communications and tender offer related correspondence. The document length (7,982 characters) and content confirm it is not a brief announcement or a regulatory filing fallback. Therefore, the classification is MA with high confidence.
2008-12-18 English
Merger & Acquisition 2008
Merger & Acquisition Classification · 100% confidence The document is a detailed correspondence letter dated December 16, 2008, from Johnson & Johnson and Binder Merger Sub, Inc. responding to SEC comments on Schedule TO filings related to a tender offer for Omrix Biopharmaceuticals, Inc. It discusses the Schedule TO-C, Schedule TO-T, and amendments, which are filings related to tender offers and takeover bids. The letter addresses regulatory comments, clarifies control issues under Rule 13e-3, and provides detailed disclosures about the tender offer process, pricing, and agreements. The presence of Schedule TO filings and the focus on tender offer details clearly indicate this document relates to merger and acquisition activity. It is not an annual report, earnings release, or other financial report, but rather a regulatory filing related to a takeover bid. Therefore, the appropriate classification is Merger & Acquisition (MA). The document length (15,000 characters) and content confirm it is not a brief announcement or certification but a substantive filing related to M&A activity.
2008-12-17 English
Merger & Acquisition 2008
Merger & Acquisition Classification · 100% confidence The document is a detailed correspondence and response letter related to Schedule TO filings, which are tender offer documents filed with the SEC. It discusses amendments and responses to SEC staff comments on the Schedule TO-C and Schedule TO-T filings, which are part of the tender offer process. The content includes detailed explanations about the tender offer, pricing, control considerations, and related agreements. This type of document is associated with merger and acquisition activity, specifically tender offers and related SEC filings. The presence of Schedule TO filings and the detailed discussion about the tender offer and merger process clearly indicates this is related to M&A activity filings. Therefore, the document should be classified under Merger & Acquisition (MA).
2008-12-16 English
PRIMARY DOCUMENT
Director's Dealing
2008-12-11 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.